The drug company's sales was down around 50 percent to Rs 184 crore. During the period, its profit too shrunk to Rs 84.3 lakh compared to Rs 18 crore on lower sales and a higher finance cost.
first published: Aug 30, 2013 02:30 pm
A collection of the most-viewed Moneycontrol videos.
You are already a Moneycontrol Pro user.

